CD4 and neoplasm: Dendritic cell-derived MHC class II molecules and tumor-derived antigenic peptides travel by separate routes and converge to form MHC class II-peptide complexes in DC/tumor FCs, where MHC class II-antigenic peptide complexes are expressed on the DC/tumor FC surface and presented to CD4+ T cells [244].